Major Changes at New York's Office of Cannabis Management
New York's Office of Cannabis Management (OCM) is undergoing a significant leadership shift as Damian Fagon, the chief equity officer, has resigned, effective immediately. His departure comes after a prolonged controversy where he was accused of retaliation—allegations that, after a comprehensive investigation, were found to be baseless.
Details on the Allegations and Their Resolution
Damian Fagon, who was instrumental to the OCM's efforts, faced serious claims from cannabis processor Jenny Argie. She alleged that Fagon retaliated against her business following her public critique of the office. This situation escalated into a lawsuit, which Argie withdrew in July after retracting her claims related to a product recall she said was initiated by Fagon.
Investigation Results
The OCM reported that an investigation carried out by the state's inspector general found no evidence supporting the accusations against Fagon. The acting executive director, Felicia Reid, shared these findings in an official email, confirming his exoneration.
Fagon's Impact on Cannabis Equity
Even though Fagon was cleared of the allegations, he chose to resign, prioritizing the transition of his equity initiatives before leaving. Over the years, he has been dedicated to promoting equity in the cannabis sector, working diligently to involve marginalized communities in the industry's growth and recognizing those most affected by previous cannabis regulations.
Leadership Transition at OCM
Fagon’s resignation represents another significant change at OCM, following the earlier departure of former executive director Chris Alexander this year. Felicia Reid has stepped in as interim executive director, a position appointed by Governor Kathy Hochul. The OCM is currently searching for a permanent replacement for Alexander, navigating the future of the office during this uncertain time, especially in relation to the equity program following Fagon's departure.
Looking Ahead in New York's Cannabis Sector
As the OCM continues its search for a new executive director, those involved in the New York cannabis community are watching closely to see how the equity program will be affected without Fagon's guidance. His work was seen as groundbreaking for promoting inclusion and creating equitable opportunities in the emerging cannabis market. His absence raises concerns about the future direction of OCM’s equity initiatives.
Ongoing Commitment to Equity
This transition period is crucial for the OCM as it seeks to promote discussions surrounding equity in the industry. The need for a more inclusive approach remains pressing, reflecting the ongoing work required to create opportunities for communities that have been disproportionately impacted by historical cannabis legislation. Stakeholders are hopeful that the new leadership will uphold a strong commitment to equity as they progress.
Frequently Asked Questions
Why did Damian Fagon resign?
Damian Fagon resigned after being cleared of retaliation claims to transition his equity work to OCM leadership.
What were the allegations against Fagon?
Fagon faced allegations of retaliation from Jenny Argie, claiming he instigated a product recall after her criticism of the OCM.
What did the investigation conclude?
The investigation by the state's inspector general found no merit to the accusations against Fagon, leading to his exoneration.
Who is the acting executive director of OCM now?
Felicia Reid currently serves as the acting executive director following Chris Alexander's departure.
What are the implications of Fagon's resignation?
Fagon's resignation adds uncertainty to the future direction and management of the OCM's equity program in the cannabis sector.
